Precision Biosciences (DTIL) Operating Margin Growth (5y) (2023 - 2026)
Precision Biosciences (DTIL) Operating Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,090.00 |
| Dec 31, 2025 | 30,200.00 |
| Sep 30, 2025 | -15.86 Mn |
| Jun 30, 2025 | -11.85 Mn |
| Mar 31, 2025 | -7.59 Mn |
| Dec 31, 2024 | -355,917.00 |
| Sep 30, 2024 | -324,182.00 |
| Jun 30, 2024 | 49,135.00 |
| Mar 31, 2024 | 33,309.00 |
| Dec 31, 2023 | 11,445.00 |
| Sep 30, 2023 | 31,691.00 |
| Jun 30, 2023 | 63,120.00 |
| Mar 31, 2023 | 45,229.00 |